KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Return on Invested Capital (2016 - 2020)

Inovio Pharmaceuticals (INO) has disclosed Return on Invested Capital for 6 consecutive years, with 0.49% as the latest value for Q3 2020.

  • Quarterly Return on Invested Capital rose 92.0% to 0.49% in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 0.49% through Sep 2020, up 92.0% year-over-year, with the annual reading at 2.38% for FY2019, 154.0% down from the prior year.
  • Return on Invested Capital hit 0.49% in Q3 2020 for Inovio Pharmaceuticals, up from 0.6% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.43% in Q3 2016 to a low of 5.19% in Q4 2019.
  • Historically, Return on Invested Capital has averaged 1.11% across 5 years, with a median of 0.8% in 2019.
  • Biggest five-year swings in Return on Invested Capital: tumbled -419bps in 2019 and later skyrocketed 92bps in 2020.
  • Year by year, Return on Invested Capital stood at 0.54% in 2016, then crashed by -31bps to 0.71% in 2017, then plummeted by -41bps to 1.01% in 2018, then tumbled by -416bps to 5.19% in 2019, then surged by 91bps to 0.49% in 2020.
  • Business Quant data shows Return on Invested Capital for INO at 0.49% in Q3 2020, 0.6% in Q2 2020, and 1.11% in Q1 2020.